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Abstract:
Acellular matrices produced by tissue decellularisation are reported to 
have tissue integrative properties. We examined the potential for 
incorporating acellular matrix grafts during procedures where there is an 
inadequate natural tissue bed to support an enduring surgical repair. 
Hypospadias is a common congenital defect requiring surgery, but 
associated with long-term complications due to deficiencies in the quality 
and quantity of the host tissue bed at the repair site. 
Biomaterials were implanted as single on-lay grafts in a peri-urethral 
position in male pigs. Two acellular tissue matrices were compared: full-
thickness porcine acellular bladder matrix (PABM) and commercially-
sourced cross-linked acellular matrix from porcine dermis (Permacol™). 
Anatomical and immunohistological outcomes were assessed 3 months 
post-surgery. 
There were no complications and surgical sites underwent full cosmetic 
repair. PABM grafts were fully incorporated, whilst Permacol™ grafts 
remained palpable. Immunohistochemical analysis indicated a non-
inflammatory, remodelling-type response to both biomaterials. PABM 
implants showed extensive stromal cell infiltration and 
neovascularisation, with a significantly higher density of cells (p< 0.001) 
than Permacol™, which showed poor cellularisation and partial 
encapsulation. 
This study supports the anti-inflammatory and tissue-integrative nature 
of non-crosslinked acellular matrices and provides proof-of-principle for 
incorporating acellular matrices during surgical procedures, such as in 
primary complex hypospadias repair. 
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Acellular matrices produced by tissue decellularisation are reported to have tissue 
integrative properties. We examined the potential for incorporating acellular matrix 
grafts during procedures where there is an inadequate natural tissue bed to support 
an enduring surgical repair. Hypospadias is a common congenital defect requiring 
surgery, but associated with long-term complications due to deficiencies in the 
quality and quantity of the host tissue bed at the repair site. 
Biomaterials were implanted as single on-lay grafts in a peri-urethral position in male 
pigs. Two acellular tissue matrices were compared: full-thickness porcine acellular 
bladder matrix (PABM) and commercially-sourced cross-linked acellular matrix from 
porcine dermis (Permacol™). Anatomical and immunohistological outcomes were 
assessed 3 months post-surgery. 
There were no complications and surgical sites underwent full cosmetic repair. 
PABM grafts were fully incorporated, whilst Permacol™ grafts remained palpable. 
Immunohistochemical analysis indicated a non-inflammatory, remodelling-type 
response to both biomaterials. PABM implants showed extensive stromal cell 
infiltration and neovascularisation, with a significantly higher density of cells (p< 
0.001) than Permacol™, which showed poor cellularisation and partial 
encapsulation. 
This study supports the anti-inflammatory and tissue-integrative nature of non-
crosslinked acellular matrices and provides proof-of-principle for incorporating 
acellular matrices during surgical procedures, such as in primary complex 
hypospadias repair. 
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Decellularised tissue matrices offer a promising natural biomaterial in surgical 
situations where there is either an inherent lack of a tissue bed for repair, or where 
the healthy tissue bed is compromised by trauma or fibrotic scarring. One such need 
is encountered in surgical repair for hypospadias. With reported frequencies of 0.3 to 
7.0 per 1000 live births, hypospadias is one of the most common genitourinary birth 
defects, requiring revision in as many as 1 in 300 boys (reviewed 1, 2). Hypospadias 
is associated with the development of a foreshortened urethra resulting in an 
aberrantly-positioned external orifice (meatus) on the ventral aspect of the penis.  
Surgical repair is the mainstay treatment for the majority of infants with hypospadias, 
but can require multiple procedures and is frequently associated with unsatisfactory 
results and complications, including the formation of urethral fistulas, stenosis and 
dehiscence or rupture of the repair. The underlying pathophysiology of many 
complications is the inherent lack of healthy host vascularised tissue, with tension on 
these inadequate tissues resulting in poor healing and dehiscence of the wound 3. 
Retrospective reviews of patient outcome following two-stage repair for severe 
hypospadias have reported complication rates from 58 to 68% 2, 4, 5.  Fistulas and 
strictures are particularly difficult to manage due to a lack, or poor quality of tissue at 
the site of repair. 
Post-operative complications increase with the severity of the anomaly 6 and patients 
with severe hypospadias often require extra tissue to repair the urethra (reviewed 1). 
Autologous free tissue grafts have been used clinically for urethral reconstruction, 
including skin from genital and extra-genital regions 7, 8, with buccal mucosa the most 
commonly used 9-11.  Problems most commonly associated with the use of 
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autologous free tissue grafts include graft size, donor site morbidity and graft 
contracture 12. Preclinical studies aimed at improving hypospadias repair outcomes 
by applying novel biomaterials and tissue-engineering techniques have met limited 
success (reviewed 2).  Such approaches have included the use of biomaterials of 
synthetic or natural derivation, either unseeded or cell-seeded in both flat and 
tubularised configurations in rabbits, dogs or rats (80 preclinical studies reviewed in 
13). A range of acellular biological scaffolds derived from allogeneic and xenogeneic 
sources using different decellularisation processes have been used in these pre-
clinical studies including porcine small intestinal submucosa (SIS, Surgisis®), 
Alloderm®, decellularised bladder submucosa and decellularised urethra 13.  Due to 
a lack of controlled preclinical studies, however, the efficacy of these approaches 
has been difficult to determine. Although pre-clinical studies in animals have tended 
to suggest better results and reduced complications when acellular matrices are 
combined with cells, such findings have not been confirmed in the limited number of 
clinical studies (reviewed 13).  However, a major confounder is the tendency to test 
novel approaches clinically only after standard surgical procedures have failed.
The ideal biomaterial to enhance urethral tissue repair would provide a suitable 
template to replicate the biological and biomechanical functional properties of the 
host tissue by allowing progressive ingrowth of periurethral tissue components, 
without inducing an adverse host response that would lead to fibrosis and 
contracture.  The size of the defect and the extent to which endogenous cells can 
infiltrate and organise within a graft material have been reported as key limitations.  
In male rabbits, a 0.5 cm tubularised decellularised matrix of porcine bladder 
submucosa was reported to be the maximum length able to support normal tissue 
formation 14. However, it is important to highlight that different decellularisation 
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methods are utilised by different research groups and different protocols can have 
varying effects on the extent of cell and DNA removal, composition of the 
extracellular matrix and biomechnical attributes of the resultant biological scaffold 
matrix resulting in variations in the potential for constructive tissue remodelling 15, 16.
We have developed proprietry decellularisation processes using low concentration 
sodium dodecyl sulphate (0.1% (w/v) SDS) and proteinase inhibitors for the 
production of a range of porcine and human tissue specific biological scaffolds 
including cardiac valves 17, 18, dermis 19, arteries 20 and musculoskeletal tissues 21, 22. 
Importantly, these processes preserve the biomechanical and biological tissue 
properties.  Preclinical 23 and clinical 24-27 studies have clearly demonstrated the 
utility of this approach. We have adapted this process for full thickness porcine 
bladder to create an acellular porcine bladder biomaterial (PABM) particularly aimed 
at urological applications 28. Using an ex vivo model in which human urinary tract 
tissue was combined with PABM in organ culture, we have previously associated 
host M2-polarised CD163+ tissue macrophages with the pioneering events of cellular 
infiltration and integration at the tissue:decellularised biomaterial interface 29.  
It is reported that Permacol™ (aka Pelvicol™), a commercial cross-linked collagen 
acellular matrix derived from porcine dermis and licenced for surgical use, may 
reduce the complications of primary complex hypospadias repair when used as a 
peri-urethral graft 3. In the off-label study, it was suggested that the graft supported 
the urethroplasty as a splint, but there was no scope for the histological outcome to 
be assessed.  Our previous in vitro studies have indicated that unlike PABM 29, 
Permacol™ lacks cell integrative properties 30.  In order to help inform future clinical 
development, the aim of this study was to evaluate gross and histological outcomes 
of incorporating PABM or Permacol™ as peri-urethral grafts in an experimental large 
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animal model. The male juvenile pig was chosen as the animal species because of 
the anatomical size and physiological similarity to male children. The cellular 
response to the implanted scaffolds at three months was studied using CD163 (M2 
macrophages) with progenitor markers of haematopoietic (CD34), leucocyte (CD45) 
and myofibroblast (SMA) lineages to assess the cell-integrative properties of non-
cross-linked and cross-linked natural biomaterial matrices. 
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For PABM production, pig bladders were collected from a local abattoir (Traves & 
Son Ltd, Escrick) on ice in Transport Medium consisting of Hank’s balanced salt 
solution (Gibco) containing 10 mM HEPES pH 7.6 (Gibco) and 20 kallikrein inhibiting 
units/ml aprotonin (Trasylol®, Nordic Pharma) 31.  PABM, a full-thickness porcine 
acellular bladder matrix, was produced aseptically using the decellularisation 
procedure described by 28, including a terminal disinfection stage with peracetic acid. 
PABM was batch-tested by histology and Hoechst 33258 staining of sections from 
multiple samples to confirm the absence of cells or double-stranded DNA.  Contact 
cytotoxicity tests conducted in vitro as described 28 confirmed both sterility and 
absence of toxic by-products.
Permacol™ was purchased from Medtronic (Watford, UK). 
Animal husbandry, analgesia and anaesthesia 
Large White Landrace Hybrid male pigs 14 weeks old of approximately 15 - 20 kg 
weight were ear-tagged for identification and housed in pairs with unlimited access to 
water. Assessment of the animals was performed at least twice daily and animals 
were weighed every two weeks. 
All experimental procedures were approved by the local Animal Welfare and Ethical 
Review Body and were conducted at the University of Leeds animal surgical facility 
under a project licence granted by the UK Home Office, in accordance with the 
Animal Scientific Procedures Act 1986. Details to fulfil the essential and 
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recommended ARRIVE 2.0 guidelines for reporting animal studies is available as 
Supplementary Information. 
Food was withheld 16 hours prior to surgery. Initial sedation was performed using 
intramuscular Midazolam 0.32mg/kg (Hypnovel Roche, UK) and Azeperone 2.25 
mg/kg (Stresnil Elanco Animla Health). An over-the-needle cannula (18g Venflon) 
was inserted and secured in an ear vein.  In some animals, where combination of 
Midazolam and Azeperoine did not produce enough sedation to allow intravenous 
catheterisation, 2.5% isoflurane in oxygen was delivered via a snout mask for no 
more than 1 minute attached to an anaesthetic machine. This deepened the state of 
sedation enough to allow intravenous catheterisation of an ear vein. Following 
intravenous catheterisation, general anaesthesia was induced by intravenous 
injection of Propofol 4.0 mg/kg or to ffect (Propofol Plus, Zoetis UK Limited). A 7-8 
mm ID endo-tracheal tube (Sims Portex Limited) was introduced and anaesthesia 
maintained using Isofluorane (2.0 – 3.0% in oxygen). 
An eye lubricant was applied and the skin was prepared for aseptic surgery using 
5% Chlorhexidine (Vetasept, Animalcare Limited). A long acting antibiotic injection, 
Amoxicillin 15mg/kg body weight (Ampoxypen LA 150mg/ml Suspension for 
Injection, MSD Animal Ltd.) and a non-steroidal anti-inflammatory drug, Carprofen 
4mg/kg body weight (Rimadyl small animal solution for injection, Zoeist UK Ltd.) 
were given subcutaneously as separate injections before the start of the surgery. 
During the surgical procedure, 0.9% NaCl (Vitevax 1 9mg/ml, Dechra Veterinary 
Products) was infused via the ear vein cannula at a rate of 40 ml/kg body weight.
At the end of the surgical procedure, 3 ml of local anaesthetic (0.5 % Marcaine, 
AstraZeneca UK) was infiltrated locally and an opioid analgesic Buprenorphine 20 
μg/kg body weight (Vetergesic 0.3 mg/ml solution for injection, CEVA Animal Health 
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Ltd) was administered as intramuscular injection to provide postoperative pain relief. 
Further post-operative analgesia was dependent on animal behaviour and was 
provided either by Buprenorphine or Carprofen alone.
Humane euthanasia involved sedation with Midazolam and Azeperone as described 
above followed by an overdose of barbiturate (phentobarbital sodium 200mg/ml 
solution; Euthatal, Merial Animal Health Ltd).
Implantation of PABM and Permacol™ as on-lay urethral free graft
Surgery was performed on 12 pigs (mean weight 16.59 kg ±1.25 SD), with six 
animals receiving implants of PABM and six of Permacol™. The study was designed 
so that procedures were carried out on half the animals (three PABM and three 
Permacol™) followed by a five month gap in order to enable the first series to be 
analysed and inform the second series.
Under anaesthesia and complete aseptic conditions, a 5 cm midline incision was 
made caudally, approximately 5 cm from the preputial sac. The peri-urethral plane 
was opened and a 3.0 by 1.5 cm2 graft of PABM or Permacol™ was positioned and 
secured with eight to ten dissolvable Vicryl™ (polyglactin 910; Ethicon) sutures, 
consistent with the surgical procedure reported in children 32.  Two non-dissolvable 
polypropylene (Prolene™, Ethicon) sutures were placed at either end of the graft in 
the opened superficial fascia in order to mark the implant site. The rest of the 
superficial fascia was closed using Vicryl™ interrupted sutures. Skin closure was 
achieved using absorbable suture in a continuous closure. Two further Prolene™ 
sutures were placed as external markers of the closure to enable location of the 
implant site after three months. 
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Euthanasia was performed three months post-operatively as planned and, following 
external inspection, implants with surrounding tissues were removed for analysis.  
Guided by the marker sutures, incisions were made and the graft and surrounding 
tissues removed en bloc, extending from the subcutaneous fat to the deep aspect of 
the penile shaft.  During tissue collection from the first cohort of pigs, free movement 
of the penile shaft within the sheath of surrounding fascia and peri-urethral tissues 
made it difficult to register the orientation of the graft in relation to the penile 
structures for histology.  To overcome this during tissue collection from the second 
set of pigs, the penile shaft and surrounding tissues were clamped before cutting 
through these structures beyond the site of the clamps.  Clamps were replaced by 
sutures once the tissue was removed from the animal and prior to fixation.   
Histology & Immunohistochemistry evaluation: qualitative and quantitative analysis
Harvested tissues were divided in two to enable separate fixation in 10% (v/v) 
formalin in phosphate buffered saline and in zinc salts.  Equivalent samples of non-
implanted PABM and Permacol™ were processed in parallel.  Following fixation, 
tissues were processed routinely into paraffin wax and 5 µm sections were collected 
onto slides. Standard haematoxylin and eosin staining was performed to evaluate 
the position and histological appearance of grafts and peri-urethral tissues. Staining 
with DNA intercalating Hoechst 33258 (0.1 µg/ml) was performed to assess tissue 
and graft cellularity. 
Immunohistochemistry was performed, in some cases on serial sections, to identify 
the nature of the cell populations surrounding or infiltrating the implants. For this 
purpose, antibodies were selected against CD34 (haematopoietic progenitor 
marker), CD45 (leucocyte/macrophage lineage marker), CD163 
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(monocytes/macrophages of an M2 tissue-remodelling phenotype), MAC387 
(recently infiltrated macrophages) and anti-smooth muscle actin (SMA expressed by 
myofibroblasts and smooth muscle cells of vascular structures).  Antibodies were 
selected on the basis of immunoreactivity against paraffin wax-embedded porcine 
tissues as listed in Table 1.  All antibodies were titrated for use, with appropriate 
positive and negative (irrelevant and no primary antibody) controls included in all 
series.  All antibody labelling was performed on zinc-fixed tissues without antigen 
retrieval, except in the case of anti-CD34, where formalin-fixed paraffin wax-
embedded sections were used.  
For zinc-fixed tissue sections, blocking of all free avidin/biotin sites (kit from Vector 
Laboratories) and secondary antibody binding sites (10 % (v/v) rabbit serum; Dako) 
was performed before incubation ov rnight at 4⁰C with primary antibody.  The 
secondary antibody, biotinylated rabbit anti-mouse immunoglobulin (Dako) was pre-
incubated with 10 % (v/v) swine serum (Dako) to eliminate cross-reactivity with 
porcine tissue.  Bound antibody was detected using the Vectastain® ABC kit (Vector 
Laboratories), with 3,3′-diaminobenzidine (DAB; SigmaFAST™ 
3,3′-diaminobenzidine tablets) as chromogen.  
For formalin-fixed sections, endogenous peroxidase was blocked with 3 % (v/v) 
hydrogen peroxide, then antigen retrieval was performed by microwave boiling in 1 
mM ethylenediamine tetra-acetic acid (pH 8.0) for 10 minutes.  Secondary antibody 
binding sites were blocked with 2.5 % (v/v) horse serum (Dako) before incubation 
overnight at 4 ⁰C with primary (anti-CD34) antibody.  Bound primary antibody was 
detected using an Amplifier™ antibody, followed by ImmPRESS™ Excel amplified 
horseradish peroxidase (HRP) polymer reagent and ImmPACT™ DAB EqV 
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substrate as the chromogen (ImmPRESS™ Excel Amplified HRP Polymer Staining 
Kit; Vector Laboratories).   
Following labelling, all sections were counterstained in Mayer's haematoxylin, 
dehydrated and mounted in 1,3-diethyl-8-phenylxanthine (DPX; Sigma-Aldrich).
Immunohistology was analysed to characterise and quantify the extent and type of 
cellularisation and tissue integration versus host reaction to the two implanted 
biomaterials (PABM and Permacol™). The analysis focused on the extent of cellular 
integration (cell type and density), presence and extent of any encapsulation 
process, and the number and distribution of immunolabelled cells.  For analysis, 
labelled slides were scanned on a Zeiss Axioscan Microscope and the resulting CZI 
image files were subjected to sup rvised semi-automated analysis using 
StrataQuest software (version 6.0.0.123) on the TissueGnostic image analysis 
platform (Vienna, Austria).  The auto-detection function was used to set the colour 
intensity of the master marker (nuclear haematoxylin) and DAB label to identify the 
different cell type-associated markers.  Five non-overlapping 0.1 x 0.1 mm2 regions 
of interest (ROIs) were defined within each implanted biomaterial (PABM and 
Permacol™) and nuclei were detected automatically within the five equal-sized 
ROIs.  Following optimisation, the same conditions were applied to all image files. 
Raw data were imported into GraphPad Prism for statistical evaluation.
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Survival and health of surgical recipients
The procedure is illustrated schematically in Figure 1 (A-D). Surgery proceeded 
according to plan with biomaterials positioned as onlay urethral grafts (Figure 1 E-G).  
All pigs survived the immediate and long-term post-operative period with no 
complications; voiding was normal and there were no episodes of urinary retention, 
urinary tract or wound infections. Upon termination at three months, the body weight 
of the animals ranged from 55-62 kg (mean 56.12 kg). Gross anatomy, as examined 
at the time of dissection and harvesting of tissue around the graft, was similar to 
control animals, with no substantial scarring, fibrosis or encapsulation. 
Macroscopically PABM grafts appeared fully integrated and could only be identifed 
from the positioning of the non-absorbable marker sutures (Figure 1H), whilst 
Permacol™ grafts remained readily apparent (Figure 1I).
Extent and patterns of cellularisation
Following dissection and histological evaluation, the biomaterial implants were 
identified in all 12 animals, as illustrated in Figure 2A-B. Samples of non-grafted 
PABM or Permacol™ processed in parallel for haematoxylin and eosin (H&E) stain 
and immunohistochemistry revealed multidirectional collagen bundles and an 
absence of cells that provided a morphological reference for identifying the implanted 
grafts.  
Histologically, there was no widespread inflammation associated with any graft and 
there was no detection of any MAC387+ cells, which would have been indicative of 
recently infiltrated macrophages.  In one Permacol™ graft, a small localised reaction 
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of giant cells within a thin capsule was found coincident with the Prolene™ marker 
suture and provided an internal control for the potential for foreign body reaction. In 
addition, occasional foci of lymphocytes were observed at the edges of Permacol™ 
samples which, based on location, frequency and distribution, related to the position 
of the Vicryl™ absorbable sutures used to attach the grafts. 
Varying extents of cellularisation were apparent within the implant sections analysed 
from the 12 grafts. Implanted PABM grafts revealed cells present uniformly 
throughout the implant (Figure 2C). There was evidence of vascularisation at the 
periphery and within the graft. This was highlighted by αSMA immunolabelling, which 
was detected on vascular elements as well as by a majority of cells within the PABM 
grafts (Figure 2E).  In the case of PABM implants, there were no lymphocytic 
aggregates found and no evidence of any encapsulation-like reaction around the 
periphery of the implant (Figure 2F).  An absence of cellularisation was typical of 
Permacol™ grafts, where cells accumulated at the edge of the implant and showed 
very limited, sparse infiltration (Figure 2D). Where present, cells showed a tendency 
to infiltrate along natural pathways within the Permacol™ grafts, sparsely infiltrating 
between collagen bundles (H&E shown in Figure 2D). Evidence of a partial 
encapsulation-like reaction, where cells accumulated  at the interface between the 
Permacol™ graft and host tissue, was apparent in some regions). This partial 
encapsulation reaction exclusive to the Permacol™ implants was particularly evident 
when sections were immunolabelled with antibodies to αSMA (Figure 2F). As 
measured from scans of all six Permacol implants, the capsule involved between 6% 
and 44% (min-max range) of the perimeter of the visualised implanted biomaterial 
(mean ±SD: 19.5% ± 12.59, n=6). The average thickness of the identified capsule 
was 216 µm ± 96 (mean ± SD, n=6; min – max range: 20 – 500 µm).  
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The nature and abundance of infiltrating cell populations
An objective quantitative analysis of immunohistochemically-labelled tissue sections 
was carried out. Total cell counts confirmed significantly higher cell densities in 
PABM than in Permacol™ implanted grafts (Figure 3).  The cell count per ROI is 
shown for each animal to illustrate the extent of variation between animals and 
across the grafts (Figure 3A).  The density of infiltrating cells expressed as the mean 
total number of cells per mm2 ± SEM was 5309 ± 78 for PABM versus 906 ± 32 for 
Permacol™ (n=6 animals per group; Figure 3B).  This difference was statistically 
significant (p < 0.0001, determined using Welch’s t-test).  
To determine if, separate from the total cell count, there were shifts in the relative 
proportions of the different major cell types infiltrating PABM and Permacol™, the 
percentages of cells expressing CD34, CD45, CD163 and αSMA was examined.  
Whereas percentages of cells expressing αSMA, CD45 and CD163 were assessed 
in serial sections, the antibody to CD34 required a different tissue fixation to be 
immunoreactive and hence was counted in equivalent but non-related areas.  The 
relative quantification revealed 40% CD34: 20% CD163: 40% αSMA positive cells in 
PABM, compared to 40% CD34: 20% CD163: 40% CD45 positive cells in 
Permacol™.  In other words, although both biomaterials were infiltrated by cells 
expressing CD34+ and/or CD163+ cells in a similar ratio, the remaining 40% of the 
infiltrating population showed a significant switch from predominantly CD45+ in 
Permacol™ to αSMA+ in PABM (Figure 4).
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The aim of hypospadias repair is to provide a good cosmetic and functional outcome, 
resulting in a penis devoid of ventral curvature and the patient being able to pass 
urine from the tip of the penis with a good stream. Our study investigated the 
concept that an acellular matrix graft inserted into a peri-urethral position would 
become tissue-integrated, augmenting a deficient tissue bed on the ventral aspect 
and reducing the potential for surgical complications. By being positioned peri-
urethrally, our approach differs in surgical approach from other studies where 
acellular matrices, either alone or seeded with cells, have been used as inlay grafts 
in urethral reconstruction in both animal and human studies (reviewed 13). 
In this present study aimed at acquiring proof-of-concept evidence towards clinical 
translation, we have demonstrated that implanting decellularised acellular tissue 
matrices into the peri-urethral stroma in a large animal surgical model is well-
tolerated and does not provoke an inflammatory response.  We compared two 
porcine matrices that varied in their different surgical handling characteristics from 
highly compliant (PABM) to stiff (Permacol™).  The handling differences are 
supported by mechanical evidence, as the Young’s modulus for Permacol™, 
reported to be 50-100 MPa 33, is considerably higher than the 2-3 MPa we found for 
native porcine bladder 34, albeit that some stiffening occurs following decellularisation 
28. Nevertheless, how different tissue derivations and/or processing affects 
biomaterial properties and influences implantation outcomes is an incomplete 
science. Bladder and dermal matrices both contain collagens type I and III, but 
whereas type III collagen is associated in the bladder with healthy compliance 35, in 
the dermis it is associated with rigidity and scarring 36, reflecting negative 
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implications for (dermal) scaffold design 37. This highlights the need for further basic 
studies to inform intelligent design, alongside empirical, translation-focused studies 
of the type reported here.  
Externally, both porcine-derived biomaterials used gave acceptable results.  
Nevertheless, there were important biological differences in the host response to the 
two materials. Implants of PABM had become fully incorporated within the three-
month period to leave no macroscopic residue.  Histologically, the marked PABM 
graft region was extensively vascularised and completely infiltrated by cells.  This 
agrees with independent reports of non-cross-linked matrices in terms of superior 
host tissue integration and cellular infiltration accompanied by neovascularisation 38, 
39. By contrast, Permacol™ implants persisted macroscopically and the bulk material 
remained acellular at three months. Permacol™ is terminally-sterilised by gamma 
radiation and chemically cross-linked by hexamethylene diisocyanate 40, the latter  
producing stable urea groups by the interaction of amine groups with isocyanate 41. 
Cross-linking is known to limit scaffold degradation 5 and to inhibit host cells from 
infiltrating matrix grafts, including Permacol™ .  Although we might predict acellular 
matrix properties to reflect tissue-specific differences, it seems axiomatic that 
observed differences in results between Permacol™ and PABM were dominated by 
the influence of cross-linking.  Supporting this point, we have shown previously that 
cells fail to infiltrate PABM cross-linked by gamma-radiation 29.  
Cells expressing αSMA+ were present both as vascular smooth muscle cells in 
association with blood vessels and as spindle-shaped myofibroblasts.  The 
myofibroblasts were present either within the PABM or in the case of Permacol™, at 
the neo-vascularised interface of the biomaterial and native host tissue where they 
formed an incomplete capsule-like structure.  An encapsulation response to 
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Permacol™ has been described in some studies 38, 42, albeit with exceptions 43.  The 
myofibroblast is recognised as an essential effector of both healthy tissue 
regeneration through matrix remodelling and pathological fibrosis, although how this 
balance is regulated is not fully understood (reviewed 44, 45).  Our observations 
suggest that the physical cross-linking of the matrix might define whether recruited 
myofibroblasts formed a boundary at the edge of the implant or infiltrated the matrix.  
Given the difference in extent of cellular infiltration into Permacol™ and PABM, we 
were interested in whether there was any relative shift in infiltrating cell types.  
Historically, any evaluation of cellularisation in implanted biomaterials has been 
performed using qualitative or semi-quantitative approaches. In the field of histology 
and immunohistochemistry, it is well known that different observers see and report 
the same tissue sample differently 46-48.  To overcome this limitation, we performed 
an objective quantitative analysis of immunohistochemically-labelled biomaterials 
three months post-implantation. Although restricted by the limited availability of 
reliable porcine-reactive antibodies, we were nevertheless able to examine the major 
infiltrating cell lineages as identified by expression of CD34 (to identify progenitor 
cells of multiple lineages, particularly haematopoietic (reviewed 49); CD45 (as a pan-
leucocyte marker); CD163 (macrophages of M2 phenotype) and αSMA (vascular and 
other smooth muscle cells, including myofibroblasts). These different markers 
revealed that after 3 months, both implanted biomaterials contained a similar 
proportion of CD34+ and CD163+ cells, making up about 60% of the total cellular 
infiltrate. The presence of CD163-expressing cells further indicated that both 
acellular collagen matrices promoted a remodelling, regenerative (M2), rather than 
inflammatory (M1) macrophage response, as observed previously with PABM in 
human ex vivo studies 29.   The remainder 40% infiltrating population was different 
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between matrices, being constituted by spindle-shaped αSMA+ cells in PABM 
versus diffuse lymphoid CD45+ cells in Permacol™. This reveals key differences in 
recellularisation biology and outcome between the two matrices, discussed below.   
Irrespective of matrix tissue derivation (bladder or dermal) or cross-linked status, 
neither acellular matrix tested provoked an acute reactive or rejection response upon 
implantation.  Nevertheless, the presence of a diffuse infiltrating CD45+ population in 
Permacol™ was indicative of a low level, chronic inflammatory state, as was 
reinforced by the presence of enhanced acute local reactions at permanent and 
resorbable suture sites.  Thus, although implanted acellular matrices were not 
themselves inflammatory and promoted an M2-type macrophage phenotype, the 
PABM was the more benign material, possibly as a result of being non-cross-linked.  
The absence of innate immune-activating signals in PABM fits with our previous 
observations using a novel ex vivo human tissue:PABM interface model, where early 
(<10 day) “pioneering” cellular events involved recruitment of tissue-resident 
macrophages and polarisation to an M2 CD163+ remodelling phenotype 29. The 
ability of PABM as a non-cross-linked allogeneic material to promote a fully 
integrative response perforce rests on the quality of matrix production, including 
absence of innate immune-inducing “danger” signals such as DNA.  This clearly 
needs stringent quality-control during batch production if the material is to be taken 
forward for clinical use. This also raises the question of sterilisation, as most terminal 
sterilisation methods involve cross-linking, such as by gamma-radiation, which our 
previous results indicate may impact negatively on tissue integrative properties 29.  
The availability of PABM and Permacol™ as biomaterials with contrasting properties 
of host integration/remodelling versus persistence may suit different surgical 
applications. The process of chemical cross-linking results in a product that remains 
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rigid but flexible and resistant to degradative processes and therefore maintains 
strength and 3D structure. This resilience of Permacol™ was exploited by Springer 
and Subramaniam to support urethral repair where Permacol™ was incorporated as 
a peri-urethral splint in 12 boys undergoing urethrocutaneous fistula repair (10) or 
redo urethroplasty (2) 32.  Apart from one instance of late wound infection, no 
recurrence of fistula or stricture was noticed in the cohort at a median follow up of 
2.5 years. The results supported the principle of managing complications from 
hypospadias surgery by incorporating a suitable biomaterial into the surgical 
procedure when local tissues are insufficient or inadequate. The clinical nature of the 
study meant that outcomes were observational only, with no possibility of obtaining 
follow-up histological evidence of the extent or nature of any tissue integration. Our 
present study highlights the importance of studying histological outcomes in a 
clinically-relevant in vivo model, as the eventual fate of the cross-linked implant 
material in the clinical study 32 is unknown. On a related point, our study 
demonstrates that even in the case of natural non-cross-linked tissue matrices, the 
complete remodelling and integration events take place over a longer timescale than 
the three months typically reported for in vivo models. 
In addition to its superior integration, other benefits of PABM are its compliance, 
malleability and ability to hold sutures. In accordance with the recognised ideal 
characteristics of a biomaterial for urethral use (reviewed 50), PABM provided a 
functional strong and supple scaffold when placed in the peri-urethral plane in a 
simple porcine urethroplasty model. From its characteristics, it is predicted that in 
primary hypospadias repair, where insufficient native tissue is available, PABM may 
fulfil an unmet surgical and clinical need as a scaffold for augmentation of the native 
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tissue in order to prevent subsequent complications, such as urethral fistulae and 
strictures.
In conclusion, this study provides proof of principle evidence that implanted acellular 
matrices become readily incorporated, meaning they may be useful to augment an 
inadequate tissue bed to support primary surgical repair. In the particular case of 
hypospadias, the successful incorporation of an onlay graft of acellular matrix during 
the primary surgery may improve the quality of repair, leading to reduced 
complications. It is clear that natural acellular tissue matrices offer promising new 
biomaterials to support reconstructive and regenerative surgery, but that many of 
their advanced physical and biological properties are negatively affected by cross-
linking as a result of conventional chemical- or radiation-induced terminal sterilisation 
procedures. If natural acellular matrices are to meet their full clinical potential it is 
important to evaluate the safety/efficacy outcomes from both ex vivo 29 and in vivo 
studies and use these to define new criteria for the regulated production of such 
materials for clinical use.    
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Table 1. Primary porcine-reactive monoclonal antibodies used for 
immunohistochemistry.
All immunohistochemistry was performed on serial zinc-fixed tissue sections with 
exception of anti-CD34 which was applied to antigen-retrieved tissue sections from 
formalin-fixed paraffin wax-embedded tissues processed in parallel.




vascular and other  
lineages
EP373Y Abcam 1:1000
CD45 Leucocyte lineage 
marker
K252-1E4 Serotec 1:150
CD163 Expressed by 
monocytes and 




SMA Vascular structures 
& myofibroblasts
1A4 Sigma 1:4000
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Figure 1.  Surgical placement of biomaterial implant (PABM or Permacol™) within 
the peri-urethral fascia. Surgery was performed on 12 Large White Landrace Hybrid 
male pigs 14 weeks old and mean weight of 16.59 kg (±1.25 (SD)). Six animals 
received implants of PABM and six of Permacol™.
A-D: Schematic of the surgical procedure. An incision (red dashed line in A) was 
made approximately 5 cm caudally from the preputial sac. The superficial adipose 
tissue was dissected (B) to reveal the peri-urethral tissues and fascia. The fascia 
was opened (B) in order that either PABM or Permacol™ could be sutured in place 
using eight Vicryl™ sutures, with two non-absorbable 3’0 Prolene® marker sutures 
positioned at either end of the graft (C). Subcutaneous fat was then opposed 
followed by skin closure (D) achieved with 5’0 Monocryl (Ethicon) or Vicryl™ 
continuous suture with two external Prolene® marker sutures at the caudal and 
cranial end of incision (D).
E-G: Intraoperative stages from surgery reflecting schematic parts B and C with 
insertion in part C of PABM (F) or Permacol™ (G).
H-I: At harvest, the grafted tissue area was removed “en-bloc” for histological 
analysis using the delineating permanent marker sutures as guides for PABM (H) 
and Pelvicol (I). Note: in H arrows highlight the persistence of Permacol™; in I,  
asterisks highlight the position of permanent stutures used to mark the position of the 
graft.
Scale bar 1 cm.
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Figure 2: Histology of on-lay graft implants after 3 months, showing PABM (left 
column) or Permacol™ (right column).
A-D: H&E-stained sections of peri-urethral penile tissue showing PABM and 
Permacol™ implants at low power (A & B), with boxes (green) marking the position of 
implant regions illustrated at higher magnification in C & D (by H&E) and E & F (by 
IHC) to examine differences in the extent of cellularisation of each biomaterial. Note 
the extensive infiltration by cells in PABM (C) marked by haematoxylin-stained nuclei 
(blue dots), compared to the absence of cells across the Permacol™ graft (pink) in 
D. Immunolabelling with anti-αSMA indicates differences in distribution of vessels 
and αSMA+ cells between PABM (E) and Permacol™ (F) implants.  PABM implants 
showed extensive cellular infiltration and neovascularisation, whereas Permacol™ 
implants showed cells and vessels r tained along the edges of the implant. Note 
partial encapsulation evident along one edge of Permacol™ (F).
Figure 3: Implant cell density. 
A: Scatter plot for number of cells detected within the biomaterial implant for each 
animal displayed individually, showing mean and SD. Using tissue analysis software, 
nuclei were detected automatically within 20 non-overlapping equal-sized regions of 
interest (ROIs) for each PABM and Permacol™ implant. Data are displayed for the 
individual animals to show the variance within and across grafts. Filled symbols 
represent PABM data and empty symbols represent Permacol™ data.
B: Combined data from all animals displayed as mean number of cells per mm2 (± 
SEM) in PABM versus Permacol™ (5309 ± 78 vs 906 ± 32; p<0.0001; n = 6 animals 
per group).
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Figure 4: Distribution of infiltrating cell types in implants.
A: Immunohistochemistry of Permacol™ and PABM implants labelled with antibodies 
against CD34, CD45, CD163 and αSMA to identify lineages of infiltrating host cell 
populations. Scale bar 100 µm.
B: Quantification of the relative propotion of different cell types in PABM and 
Permacol™ samples identified using cell type lineage markers. Supervised 
automated image analysis using StrataQuest software was used to quantify cell 
numbers from 5 individual ROIs per implant for each marker. Data expressed as 
mean ± SD.
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Figure 1.  Surgical placement of biomaterial implant (PABM or Permacol™) within the peri-urethral fascia. 
Surgery was performed on 12 Large White Landrace Hybrid male pigs 14 weeks old and mean weight of 
16.59 kg (±1.25 (SD)). Six animals received implants of PABM and six of Permacol™. 
A-D: Schematic of the surgical procedure. An incision (red dashed line in A) was made approximately 5 cm 
caudally from the preputial sac. The superficial adipose tissue was dissected (B) to reveal the peri-urethral 
tissues and fascia. The fascia was opened (B) in order that either PABM or Permacol™ could be sutured in 
place using eight Vicryl™ sutures, with two non-absorbable 3’0 Prolene® marker sutures positioned at either 
end of the graft (C). Subcutaneous fat was then opposed followed by skin closure (D) achieved with 5’0 
Monocryl (Ethicon) or Vicryl™ continuous suture with two external Prolene® marker sutures at the caudal 
and cranial end of incision (D). 
E-G: Intraoperative stages from surgery reflecting schematic parts B and C with insertion in part C of PABM 
(F) or Permacol™ (G). 
H-I: At harvest, the grafted tissue area was removed “en-bloc” for histological analysis using the delineating 
permanent marker sutures as guides for PABM (H) and Pelvicol (I). Note: in H arrows highlight the 
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persistence of Permacol™; in I,  asterisks highlight the position of permanent stutures used to mark the 
position of the graft. 
Scale bar 1 cm. 
157x221mm (150 x 150 DPI) 
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Figure 2: Histology of on-lay graft implants after 3 months, showing PABM (left column) or Permacol™ (right 
column). 
A-D: H&E-stained sections of peri-urethral penile tissue showing PABM and Permacol™ implants at low 
power (A & B), with boxes (green) marking the position of implant regions illustrated at higher magnification 
in C & D (by H&E) and E & F (by IHC) to examine differences in the extent of cellularisation of each 
biomaterial. Note the extensive infiltration by cells in PABM (C) marked by haematoxylin-stained nuclei (blue 
dots), compared to the absence of cells across the Permacol™ graft (pink) in D. Immunolabelling with anti-
αSMA indicates differences in distribution of vessels and αSMA+ cells between PABM (E) and Permacol™ (F) 
implants.  PABM implants showed extensive cellular infiltration and neovascularisation, whereas Permacol™ 
implants showed cells and vessels retained along the edges of the implant. Note partial encapsulation 
evident along one edge of Permacol™ (F). 
150x174mm (150 x 150 DPI) 
Page 34 of 40
http://mc.manuscriptcentral.com/tej































































Figure 3: Implant cell density. 
A: Scatter plot for number of cells detected within the biomaterial implant for each animal displayed 
individually, showing mean and SD. Using tissue analysis software, nuclei were detected automatically 
within 20 non-overlapping equal-sized regions of interest (ROIs) for each PABM and Permacol™ implant. 
Data are displayed for the individual animals to show the variance within and across grafts. Filled symbols 
represent PABM data and empty symbols represent Permacol™ data. 
B: Combined data from all animals displayed as mean number of cells per mm2 (± SEM) in PABM versus 
Permacol™ (5309 ± 78 vs 906 ± 32; p<0.0001; n = 6 animals per group). 
168x200mm (150 x 150 DPI) 
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Figure 4: Distribution of infiltrating cell types in implants. 
A: Immunohistochemistry of Permacol™ and PABM implants labelled with antibodies against CD34, CD45, 
CD163 and αSMA to identify lineages of infiltrating host cell populations. Scale bar 100 µm. 
B: Quantification of the relative propotion of different cell types in PABM and Permacol™ samples identified 
using cell type lineage markers. Supervised automated image analysis using StrataQuest software was used 
to quantify cell numbers from 5 individual ROIs per implant for each marker. Data expressed as mean ± SD. 
130x226mm (150 x 150 DPI) 
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ARRIVE guidelines 2.0.  https://arriveguidelines.org/
Essential 10
1a The groups being compared We developed a porcine experimental model of 
urethroplasty to study the effect of incorporating an 
onlay free graft of acellular matrix at the repair site.  We 
compared two acellular matrices: 1) PABM (Porcine 
Acellular Bladder Matrix a non-crosslinked, full thickness 
matrix) and 2) Permacol™ (a commercial porcine dermis-
derived acellular matrix that is licensed for human use 
and has previously been used as an off-label product in a 
small clinical series undergoing hypospadias repair). 
1b The experimental unit Single animal
2a Experimental units allocated to 
each group and total number in 
each experiment; total number 
of animals used
Twelve large white hybrid (LWH) pigs were used in the 
experimental study with a total of six animals implanted 
with PABM and six with Permacol. 
2b How sample size was decided A maximum of 6 pigs could be housed at any one time
3a Inclusion or exclusion criteria 
and data points during the 
analysis
Only male pigs were used - both sexes of animal were 
not used because the study was targeted for a condition 
that does not occur in females.  
All animals included in the study remained healthy and 
none were excluded at any stage of the study
3b Any animals not included in the 
analysis and why. 
NA
3c Report exact value of n in each 
group
12 animals total in 2 groups of n=6 each.  
4a Randomisation of animals to 
control and treatment groups
Six animals were implanted with PABM and six with 
Permacol™. The animals were divided into two groups of 
six with three pigs having PABM and the other 
Permacol™ implanted into the peri-urethral tissues. The 
surgery for first and second groups took place ~five 
months apart.
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4b Strategy to minimise 
experimental confounders
Surgery was performed in two batches of 6 to limit
any inherent bias that may have ensued by implanting 
only Permacol™ or PABM first, thereby improving the 
surgical procedure used for the second batch of six.
5a Blinding – who was aware of 
group allocation during 
allocation, conduct, outcome 
and data analysis 
To perform blinded analysis, labelled slides were 
scanned on a Zeiss Axioscan Microscope and the 
resulting CZI image files were subjected to semi-
automated supervised analysis using StrataQuest 
software (version 6.0.0.123) on the TissueGnostic image 
analysis platform (Vienna, Austria). Five non-overlapping 
0.1 x 0.1 mm2 regions of interest (ROIs) were defined 
within each implanted biomaterial (PABM and 
Permacol™) and nuclei were detected automatically 
within the five equal-sized ROIs. Following optimisation, 
the same conditions were applied to all image files. 
6a Define outcome measures Weight gain; Normal voiding function; External 
palpability; Histological evaluation of capsule formation; 
inflammation; cellularisation by density & cell type. 
7a Statistical methods and 
software
Raw data were imported into GraphPad Prism for 
statistical evaluation using descriptive statistics. 
8a Species, strain, gender, age, 
weight
Large white hybrid (LWH) male animals averaging 16.59 
kg ± 1.25.
9a Experimental procedures – 
what, where, when and why
During the surgical implantation of the grafts, the peri-
urethral plane was opened. The graft was secured with 
eight dissolvable Vicryl™ (polyglactin 910; Ethicon)
sutures. Two Prolene® (polypropylene; Ethicon) non-
dissolvable “marker” sutures were placed at either end 
of the opened superficial fascia to the graft to enable 
localisation of the implant site. The rest of the superficial 
fascia and subcutaneous fat (where necessary) was 
closed using Vicryl™ interrupted sutures. Skin closure 
was achieved using Vicryl™ or Monocryl® in a continuous 
closure. Two further Prolene® sutures were placed as 
external markers of the closure to enable successful 
location of the site at 3 months. 
10a Summary/descriptive stats for 
each experimental group plus 
variance
Upon termination at three months, the body weight of 
the animals ranged from 55-62 kg (mean 56.12 kg).
In the Permacol group only, there was a partial 
encapsulation reaction involving between 6% and 44% 
(min-max range) of the perimeter of the visualised 
implanted biomaterial (mean ±SD: 19.5% ± 12.59, n=6). 
The average thickness of the identified capsule was 216 
μm ± 96 (mean ± SD, n=6; min-max range: 20 - 500 μm).
The density of infiltrating cells expressed as the mean 
total number of cells per mm2 ± SEM was 5309 ± 78 for 
PABM versus 906 ± 32 for Permacol™ (n=6 animals per 
group; p < 0.0001 using Welch t test).
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Relative quantification revealed 40% CD34: 20% CD163: 
40% αSMA positive cells in PABM, compared to 40% 
CD34: 20% CD163: 40% CD45 positive cells in 
Permacol™.  Thus, although both biomaterials were 
infiltrated by cells expressing CD34+ and/or CD163+ cells 
in a similar ratio, the remaining 40% of the infiltrating 
population showed a significant switch from 
predominantly CD45+ in Permacol™ to αSMA+ in PABM.
Recommended set
11 Abstract Acellular matrices produced by tissue decellularisation are 
reported to have tissue integrative properties. We examined 
the potential for incorporating acellular matrix grafts during 
procedures where there is an inadequate natural tissue bed to 
support an enduring surgical repair. Hypospadias is a common 
congenital defect requiring surgery, but associated with long-
term complications due to the poor quality/quantity of 
underlying tissue bed at the repair site. 
Biomaterials were implanted as single on-lay 3.0 by 1.5 cm2 
grafts of PABM or Permacol™ in a peri-urethral position in 
male pigs. Two acellular tissue matrices were compared: full-
thickness porcine acellular bladder matrix (PABM) and 
commercially-sourced cross-linked acellular matrix from 
porcine dermis (Permacol™). Anatomical and 
immunohistological outcomes were assessed 3 months post-
surgery.
There were no complications and surgical sites underwent full 
cosmetic repair. PABM grafts were fully incorporated, whilst 
Permacol™ grafts remained manipulatable. Immuno-
histochemical analysis indicated a non-inflammatory,
remodelling-type response to both biomaterials. PABM 
implants showed extensive stromal cell infiltration and 
neovascularisation, with a significantly higher density of
cells (p< 0.001) than Permacol™, which showed poor 
cellularisation and partial encapsulation.
This study supports the anti-inflammatory and tissue-
integrative nature of non-cross-linked acellular matrices and 
provides proof-of-principle for incorporating acellular 
matrices during surgical procedures, such as in primary 
complex hypospadias repair.
12a Background, rationale and 
experimental approach
Background 
There is a clinical need in urology to identify biomaterials that 
can be used for reconstructive surgery of the lower urinary 
tract, including the bladder and urethra. Hypospadias is one of 
the most common birth defects in males (1 in 300) and is 
associated with development of an abnormal urethra.  
Surgical repair is performed for a majority of infants with 
hypospadias, but repair of severe hypospadias may require 
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multiple procedures and is frequently associated with 
unsatisfactory results, including the formation of urethral 
fistulas in up to 20% of cases.  These fistulas may be persistent 
and difficult to manage due to a lack of, or poor quality, tissue 
at the site of repair.  Success rates for fistula repair with 
multiple attempts is unsatisfactory (between 66.6% and 92%) 
and recurrence rates are highest with simple closure.  
Rationale
Our rationale was that natural biomaterials may support 
surgical repair and if incorporated in primary hypospadias 
cases could reduce the incidence of complications.   
Experimental procedures.
Anaesthesia
Food but not water was withheld for 18 hours prior to 
surgery. Initial sedation was performed using intramuscular 
Hypnovel (0.3 mg/kg) (Roche) and Stresnil (1.2 mg/kg)
(Elanco). The animal was left for 20-30 minutes in a quiet and 
calm environment before transportation to the anaesthetic 
room on a trolley. Induction of anaesthesia was achieved by 
utilising a snout mask containing an isoflurane-soaked. 
Isoflurane 2.5 % in oxygen was then used for maintenance of 
anaesthesia and delivered via the snout mask attached to an 
anaesthetic machine. The electrocardiogram, pulse, blood
pressure and oxygen saturation of the animal was 
continuously monitored during the surgical procedure. Eyes 
were protected using Lacri-lube® (Allergan-Actavis).
An over-the-needle intravenous cannula (22 G) was 
introduced into an ear vein and secured with Micropore ™ 
(3M). The animal was given AmoxyPen LA (MSD Animal
Health) (15 mg/kg) and Rimadyl (Zoetis) (2 mg/kg), a non-
steroidal anti-inflammatory agent
Positioning for surgery
The anaesthetised animal was place supine on the operating 
table.  Skin on the lower abdomen was shaved. A plate 
electrode (Conmed) was placed onto shaved flank skin and 
attached to the diathermy machine. The animal’s skin was 
prepared with Chlorhexidine solution (Vetasept-Animal Care). 
The animal was draped using 307 x 254cm StreriDrapes with
incise pouch (3M). The monopolar diathermy pen (Ambu) was 
attached to the diathermy machine.
Surgical Basics:
A 5cm midline incision was made, approximately 5cm from 
the preputial sac, caudally using a size 15 disposable scalpel 
(Swann Morton). The peri-urethral tissues were opened using 
blunt dissection. Bleeding was stopped, when necessary using
monopolar diathermy. 
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At skin closure 3ml of 0.5 % Marcaine local anaesthetic was 
infiltrated locally. In addition, Vetergesic (0.3 mg), an opioid 
analgesic was administered to provide postoperative
pain relief. The animal was transferred from the operating 
table to trolley and then to a pen with fresh bedding and 
sawdust. The animal was allowed to recover in a quiet 
environment in isolation until up on all four limbs and drinking 
water. Once this was achieved the animal was placed in a pen 
with another animal and food made available.
Schedule 1
The process of euthanasia began with sedation of the animal 
using Hypnovel and Stresnil. An ear vein was cannulated and 
barbiturate was administered intravenously to overdose.
12b Relevance to humans In order to be relevant to children, a large surgical model was 
required to test surgical compatibility and provide an 
adequate model in terms of anatomical size.
13 Objectives The aim was to develop a large experimental model 
equivalent to anatomical size to children, in which to test 
surgical compatibility and examine the potential use of PABM 
in paediatric urology. The following experimental objectives 
were investigated:
- To d termine the cellular integration properties of PABM 
when surgically implanted in vivo as a free onlay graft in a 
peri-urethral position
- To compare the integration of non-crosslinked PABM with 
that of a commercially-available crosslinked decellularised 
dermal matrix (Permacol™)
14 Ethical statement All experimental procedures were approved by the local 
Animal Welfare and Ethical Review Body and were conducted 
at the University of Leeds animal surgical facility under a 
project licence granted by the UK Home Office, in accordance 
with the Animal Scientific Procedures Act 1986 under project 
licence (PPL70/7930).  
15 Housing and husbandry Large White Hybrid (LWH) male pigs were transported to the 
animal surgical facility for seven days quarantine. Numbered 
ear tags were used to aid individual identification. The animals 
were inspected for signs of disease by a vet and the facility’s 
technical staff and animals were housed together in pens, 
with appropriate clean bedding.
16 Animal care and 
monitoring
All animals were monitored and evaluated at least 
twice/day.  The animals were weighed every two weeks 
over the full period and feeding regime altered 
accordingly. Food was available up to twice a day, with 
the amount varying according to weight gain and 
behaviour. Access to water was unlimited. 
17 Interpretation/scientific 
implications
Implanting an acellular tissue matrix into the peri-urethral 
stroma in a large animal surgical model is safe and does not 
provoke an inflammatory response. Superficially, both the 
porcine-derived biomaterials used gave outwardly acceptable 
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results. Nevertheless, there were important biological 
differences in the host response to the two materials. 
Implants of PABM had become fully incorporated within the 
three-month period to leave no macroscopic residue. 
Histologically, the marked PABM graft region was extensively
vascularised and completely infiltrated by cells. This agrees 
with independent reports of non-cross-linked matrices in 
terms of superior host tissue integration and cellular 
infiltration accompanied by neovascularisation. By contrast, 
Permacol™ implants persisted macroscopically and the bulk 
material remained acellular at three months. This is consistent 
with other studies using cross-linked biomaterials, including 
changes we ourselves have noted following PABM 
crosslinking.  
18 Generalisability/translation The experiments were performed in a surgical model of 
relevant scale and provide support to the principle of 
managing complications from hypospadias surgery by 
incorporating a suitable biomaterial into the surgical 
procedure when local tissues are insufficient or inadequate. 
By providing histological evidence of the extent and nature of 
tissue integration outcomes when different biomaterials are 
used, the results add important insight to small scale clinical 
studies where outcomes have been observational only.
19 protocol registration NA
20 Data Access Access to the raw histological qualitative and quantitative 
data required to reproduce the findings is available on request 
from the corresponding author. 
21 Declaration of interests The work was partially funded through the Medical 
Technologies Innovation and Knowledge Centre (phase 2 - 
Regenerative Devices), funded by the EPSRC under grant 
number EP/N00941X/1 as Proof of Concept awards: PoC023 
and PoC045. AR was supported by the European Society of 
Paediatric Urology. JS is supported by a programme grant 
from York Against Cancer. The work leading to the 
development of PABM was originally funded by the 
Biotechnology and Biological Sciences Research Council 
(BBSRC) on grants E20352 and BB/E527220/1.
Eileen Ingham is a shareholder and consultant to Tissue 
Regenix Group PLC. The authors confirm that there are no 
other known conflicts of interest associated with this 
publication and there has been no significant financial support 
for this work that could have influenced its outcome.
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